Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations.
Azar I, Khan HY, Bannoura SF, Gandhi N, Uddin MH, Nagasaka M, Gong J, Nazha B, Choucair K, Vojjala N, Khushman MM, Soares HP, El-Deiry WS, Philip PA, El-Rayes B, Chen H, Lou E, Muqbil I, Farrell AP, Swensen J, Oberley MJ, Nabhan C, Goel S, Shields AF, Mohammad RM, Pasche BC, Azmi AS.
Azar I, et al. Among authors: gandhi n.
JCO Oncol Adv. 2025 May 2;2(1):e2400032. doi: 10.1200/OA-24-00032. eCollection 2025.
JCO Oncol Adv. 2025.
PMID: 40330142
Free PMC article.